Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-Acetate PET/CT for Neuroinflammation in AD
NCT02811744Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- Jan 2017
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Phase 2, open-label trial (2 cohorts), sponsored by University of Pennsylvania. Primary endpoint: 11C-acetate Uptake in Amyloid Positive Mild Cognitive Impairment (MCI) Subjects Versus Amyloid Negative Healthy Controls at 6 months. Started Jan 2017; status: terminated.
Beyond the preview
Go deeper on NCT02811744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02811744.